
@statnewsi
🇺🇸Account based in
About this account
- Account based in
- United States
- Connected via
- Web
Account-level information from X, not a live location or the device used for a specific post.
Reporting from the frontiers of health & medicine. Sign up for any of our newsletters here: https://xitter.cf/t.co/CBx3GZBv31
Joined July 2015
- Tweets89.5K
- Following4.7K
- Followers165K
- Likes45K
This year, as in past years, we’ve found inspiring stories and innovative research. All are blazing new trails as they attempt to answer some of the biggest questions in science and medicine.
Meet the 2026 #STATWunderkinds!
statnews.com/wunderkinds/
STAT retweeted
I spoke with Moderna $MRNA CEO Stéphane Bancel about intismeran and what's next for the cancer vaccine and the biotech he runs.
"We know the clinical impact in the Phase 3 study is real and big, so we need to go and be aggressive. We need to explore the biology. There will be some risk, because it’s not going to work everywhere."
Read the Q&A:
statnews.com/2026/10/26/mode… #ESMO26
For the first time, a human has been infected with the Shamonda virus, according to French officials. The World Health Organization says broader transmission is unlikely. trib.al/sJiQQss
“We shouldn't confuse illness and the hardships that come with living,” writes family nurse practitioner Kirsten Balin. trib.al/UpGms3U
“What we don’t know is whether people are disconnecting from one another, gradually, over months of interacting with chatbots,” researchers write. trib.al/rU5iKnd
New guidance is intended to help girls and women — and their doctors — recognize four distinct phases in heart health. trib.al/OG4a4MQ
The center will study the long-term impact of infections, in addition to RFK Jr.'s focus on vaccines. trib.al/J0aEERU
Moderna's CEO Stéphane Bancel on what's next after the recent success in cancer vaccine, and how that impacts the company's business strategy. trib.al/fn9nyhn
STAT retweeted
After a cancer vaccine’s first success, the race is on to expand the impact statnews.com/2026/10/25/mrna…
After a cancer vaccine’s first success, the race is on to expand the impact statnews.com/2026/10/25/mrna…
AstraZeneca has seen major momentum in oncology in recent years. It got a big showcase at Europe's top cancer conference. trib.al/Zu2UXXm
MADRID — With the first pivotal trial showing a customized mRNA treatment improved outcomes for cancer patients presented here this weekend, the conversation has already turned to how melanoma specialists… trib.al/P7WcLvg
Moderna and Merck's 'presidential' presentation, and other news from Day 2 of the European Society for Medical Oncology meeting in Madrid. trib.al/BVfeUZc
“Even if Theranos had a functioning testing machine, the economic model on which is was based would result in failure,” writes a STAT reader. trib.al/sUVV1lK
“The goal is not simply to diagnose MS faster. It is to get the diagnosis right,” writes Bruce Bebo. trib.al/sAmwy2u
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry. trib.al/tLLsZMP
Most new cancer medicines approved by European regulators over a recent four-year period do not offer high clinical benefit, a new analysis finds. trib.al/c8S5NM0
A special episode of "The Readout LOUD" podcast: Remembering Helen Branswell
Listen: statnews.com/2026/10/23/read…
At last week’s #STATSummit, Dana Senaha told the story of her husband’s experience participating in the clinical trial for daraxonrasib.
Watch: One family’s story of a life-extending medicine for pancreatic cancer
bit.ly/4zVbNnP
The American Diabetes Association has issued two explanations, two reviews and an apology over its June convention. A Friday report adds new twists. trib.al/C2alBV1

